创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

MIAO Jiaying, LU Wei. Research Progress of Non-viral Vector Delivery System for mRNA Vaccine[J]. Progress in Pharmaceutical Sciences, 2022, 46(2): 84-92.
Citation: MIAO Jiaying, LU Wei. Research Progress of Non-viral Vector Delivery System for mRNA Vaccine[J]. Progress in Pharmaceutical Sciences, 2022, 46(2): 84-92.

Research Progress of Non-viral Vector Delivery System for mRNA Vaccine

  • Compared with traditional vaccines, nucleic acid vaccines can induce a more comprehensive and durable immune response, and are manufactured more quickly. Among them, mRNA vaccines can be precisely designed, with good tolerance and strong immune response. In comparison with DNA vaccines, the expression mechanism of mRNA vaccines is safer and simpler, showing great potential of broad application. However, since mRNA vaccines are unstable and can't easily penetrate cell membranes, it is critical to design delivery systems that can protect mRNA vaccines and deliver them to target cells. In this review, we highlight the features and research progress of lipids, polymers, peptides and other non-viral vectors and (or) delivery systems used for in vivo delivery of mRNA vaccines, and also give an outlook on the research prospect of mRNA vaccines.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return